financetom
Business
financetom
/
Business
/
Yum! Brands' Q3 Adjusted Earnings Decline, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Yum! Brands' Q3 Adjusted Earnings Decline, Revenue Increases
Nov 5, 2024 7:58 PM

07:20 AM EST, 11/05/2024 (MT Newswires) -- Yum! Brands ( YUM ) reported Q3 adjusted earnings Tuesday of $1.37 per diluted share, down from $1.44 a year earlier.

Analysts polled by Capital IQ expected $1.41.

Revenue for the quarter ended Sept. 30 was $1.83 billion, compared with $1.71 billion a year earlier.

Analysts polled by Capital IQ expected $1.89 billion.

Price: 132.75, Change: -0.01, Percent Change: -0.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Teledyne Technologies Unit Wins $15 Million Contract to Provide Nano Drones to German Armed Forces
Teledyne Technologies Unit Wins $15 Million Contract to Provide Nano Drones to German Armed Forces
Feb 26, 2025
05:53 AM EST, 02/26/2025 (MT Newswires) -- Teledyne Technologies ( TDY ) said Wednesday its Teledyne FLIR Defense subsidiary received a $15 million order to provide its Black Hornet 4 nano drones to the German armed forces. The two-year agreement includes the delivery of drones, parts and training, the company said. ...
BridgeBio Pharma Prices $500 Million Convertible Senior Notes Offering
BridgeBio Pharma Prices $500 Million Convertible Senior Notes Offering
Feb 26, 2025
05:52 AM EST, 02/26/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Wednesday it priced $500 million of 1.75% convertible senior notes due March 1, 2031 in a private offering, for about $489.5 million in expected net proceeds. The company granted the initial purchasers an option to buy up to an additional $75 million of notes. BridgeBio said it...
ACM Research Q4 Non-GAAP Earnings, Revenue Rise
ACM Research Q4 Non-GAAP Earnings, Revenue Rise
Feb 26, 2025
05:49 AM EST, 02/26/2025 (MT Newswires) -- ACM Research ( ACMR ) reported Q4 non-GAAP earnings Wednesday of $0.56 per diluted share, up from $0.43 a year earlier. Four analysts polled by FactSet expected $0.39. Revenue for the quarter ended Dec. 31 was $223.5 million, up from $170.3 million a year earlier. Analysts surveyed by FactSet expected $194.9 million. For...
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Feb 26, 2025
Feb 26 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Wednesday: ** Switzerland-based pesticides maker Syngenta said that it has acquired a repository of natural compounds and genetic strains from drugmaker Novartis to further boost the development of biologic crop protection. ** Italian lender UniCredit has reported its planned acquisition of a 29.99%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved